HCPCS Level II J1932: Injection, lanreotide, 1 mg
HCPCS Level II code J1932 describes a medication administration billing unit for injection of lanreotide (cipla), specified as 1 mg per unit; the service represents a therapeutic injectable medication typically administered via intramuscular or deep subcutaneous injection in outpatient clinics, physician offices, or infusion centers and is used to bill for each 1 mg vial or dose of lanreotide provided to the patient.
Customize your policy alerts
Sign up for hcpcs J1932 policy alerts
Get alerted when payer policies referencing J1932 are released or updated.
Monitor payer policy activity